Established in the year 1990, with Research & Development as its prime fundamental, Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. The company in a matter of short time expanded its breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry.
With five years of experience, expertise and a proven track-record of helping many companies with its turn-key and consulting strengths, Divis Laboratories established its first manufacturing facility in 1995.
Built on a 500 acre site at Hyderabad (Unit-I). the plant comprises of 13 multi-purpose production blocks and has space for further growth and expansion.
Divis Laboratories set up its second manufacturing facility at Visakhapatnam (Unit-II). in the year 2002 on a 350 acre site. The site has 14 multi purpose production blocks.
Both the facilities are primarily engaged in the manufacture of:
Active Pharmaceutical Ingredients (APIs) & Intermediates for Generics
Custom Synthesis of API's and Advanced intermediates for discovery compounds for
pharma giants
Building blocks for Peptides
Building blocks for Nucleotides
Carotenoids
Chiral ligands
Complete cGMP guidelines are complied with in both the plants. Our Unit-1 at Hyderabad was successfully inspected by the US FDA during September 2000, in April 2004 and in February 2008. Our Unit-2 at Visakhapatnam was successfully inspected by the US FDA during November 2006 and in April 2009. Divis also undertakes FTE/Contract Research on process development for discovering new compounds for leading MNCs across the world and partners with them for the supply of APIs. The company is global in its outlook and benchmarks its quality standards to the best in the world.
India
